Literature DB >> 32447634

Gut Microbial Predictors of Type 2 Diabetes Remission Following Bariatric Surgery.

Naomi Davies1,2, Justin M O'Sullivan2,3, Lindsay D Plank4, Rinki Murphy5,6.   

Abstract

PURPOSE: Distinct anatomical rearrangements of the gastrointestinal tract achieved by various types of bariatric surgery cause changes in nutrient intake and gut microbiota. The contribution of such gut microbiota changes to remission of type 2 diabetes (T2D) remains unclear. AIM: We examined gut microbiota changes following banded Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) in a randomised study, in relation to T2D remission.
MATERIALS AND METHODS: Whole-metagenome shotgun sequencing was carried out on paired stool samples at pre- and 1-year post-surgery collected from 44 participants with T2D randomised to banded Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG). Taxonomic composition and predicted functional potential of the gut bacteria were identified using HUMANn2, and annotated using MetaCyc. Five-day dietary records (analysed using FoodWorks v8.0), body weight and diabetes status were recorded at both time points.
RESULTS: RYGB participants had higher percentage excess weight loss than SG (p = 0.01), even though dietary intake was similar at 1-year post-surgery. Similar proportions achieved diabetes remission (HbA1c < 48 mmol/mol without medications) after either RYGB (68%) or SG (59%). RYGB resulted in increased abundances of Firmicutes and Proteobacteria, while SG resulted in increased Bacteroidetes. Pre-surgery, an increased abundance of Eubacteriaceae (p = 0.01) and Alistipes putredinis (p = 0.01) was observed in those who went on to remit from T2D post-surgery. Following surgery, Lachnospiraceae (p = 0.04) and Roseburia (p = 0.01) species were more abundant in those who had achieved T2D remission.
CONCLUSIONS: Specific stool bacterial taxa may signal likelihood of T2D remission after bariatric surgery which is potentially mediated by increases in Lachnospiraceae and Roseburia.

Entities:  

Keywords:  Bacteria; Bariatric surgery; Bypass; Diabetes; Fecal microbiota; Obesity

Mesh:

Year:  2020        PMID: 32447634     DOI: 10.1007/s11695-020-04684-0

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  40 in total

1.  Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects.

Authors:  J Vidal; A Ibarzabal; F Romero; S Delgado; D Momblán; L Flores; A Lacy
Journal:  Obes Surg       Date:  2008-06-03       Impact factor: 4.129

2.  Bariatric surgery versus intensive medical therapy in obese patients with diabetes.

Authors:  Philip R Schauer; Sangeeta R Kashyap; Kathy Wolski; Stacy A Brethauer; John P Kirwan; Claire E Pothier; Susan Thomas; Beth Abood; Steven E Nissen; Deepak L Bhatt
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

3.  Laparoscopic Sleeve Gastrectomy Versus Banded Roux-en-Y Gastric Bypass for Diabetes and Obesity: a Prospective Randomised Double-Blind Trial.

Authors:  Rinki Murphy; Michael G Clarke; Nicholas J Evennett; S John Robinson; M Lee Humphreys; Hisham Hammodat; Bronwen Jones; David D Kim; Richard Cutfield; Malcolm H Johnson; Lindsay D Plank; Michael W C Booth
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

4.  A metagenome-wide association study of gut microbiota in type 2 diabetes.

Authors:  Junjie Qin; Yingrui Li; Zhiming Cai; Shenghui Li; Jianfeng Zhu; Fan Zhang; Suisha Liang; Wenwei Zhang; Yuanlin Guan; Dongqian Shen; Yangqing Peng; Dongya Zhang; Zhuye Jie; Wenxian Wu; Youwen Qin; Wenbin Xue; Junhua Li; Lingchuan Han; Donghui Lu; Peixian Wu; Yali Dai; Xiaojuan Sun; Zesong Li; Aifa Tang; Shilong Zhong; Xiaoping Li; Weineng Chen; Ran Xu; Mingbang Wang; Qiang Feng; Meihua Gong; Jing Yu; Yanyan Zhang; Ming Zhang; Torben Hansen; Gaston Sanchez; Jeroen Raes; Gwen Falony; Shujiro Okuda; Mathieu Almeida; Emmanuelle LeChatelier; Pierre Renault; Nicolas Pons; Jean-Michel Batto; Zhaoxi Zhang; Hua Chen; Ruifu Yang; Weimou Zheng; Songgang Li; Huanming Yang; Jian Wang; S Dusko Ehrlich; Rasmus Nielsen; Oluf Pedersen; Karsten Kristiansen; Jun Wang
Journal:  Nature       Date:  2012-09-26       Impact factor: 49.962

5.  Altered gut microbiome after bariatric surgery and its association with metabolic benefits: A systematic review.

Authors:  Naomi K Davies; Justin M O'Sullivan; Lindsay D Plank; Rinki Murphy
Journal:  Surg Obes Relat Dis       Date:  2019-02-07       Impact factor: 4.734

6.  Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial.

Authors:  Wei-Jei Lee; Keong Chong; Kong-Han Ser; Yi-Chih Lee; Shu-Chun Chen; Jung-Chien Chen; Ming-Han Tsai; Lee-Ming Chuang
Journal:  Arch Surg       Date:  2011-02

Review 7.  Bariatric surgery: risks and rewards.

Authors:  Walter J Pories
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

Review 8.  Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.

Authors:  Henry Buchwald; Rhonda Estok; Kyle Fahrbach; Deirdre Banel; Michael D Jensen; Walter J Pories; John P Bantle; Isabella Sledge
Journal:  Am J Med       Date:  2009-03       Impact factor: 4.965

9.  [Complications of postoperative systematic preventive anticoagulant treatment].

Authors:  R Rettori
Journal:  J Mal Vasc       Date:  1989

10.  A core gut microbiome in obese and lean twins.

Authors:  Peter J Turnbaugh; Micah Hamady; Tanya Yatsunenko; Brandi L Cantarel; Alexis Duncan; Ruth E Ley; Mitchell L Sogin; William J Jones; Bruce A Roe; Jason P Affourtit; Michael Egholm; Bernard Henrissat; Andrew C Heath; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

View more
  6 in total

1.  Investigating Ramadan Like Fasting Effects on the Gut Microbiome in BALB/c Mice.

Authors:  Junhong Su; Fanglin Li; Yueying Wang; Yuxin Su; Auke Verhaar; Zhongren Ma; Maikel P Peppelenbosch
Journal:  Front Nutr       Date:  2022-05-12

2.  Effect of Banded Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy on Diabetes Remission at 5 Years Among Patients With Obesity and Type 2 Diabetes: A Blinded Randomized Clinical Trial.

Authors:  Rinki Murphy; Lindsay D Plank; Michael G Clarke; Nicholas J Evennett; James Tan; David D W Kim; Richard Cutfield; Michael W C Booth
Journal:  Diabetes Care       Date:  2022-07-07       Impact factor: 17.152

3.  Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy.

Authors:  Yinhua Huang; Zhijie Wang; Hongjie Ma; Shangli Ji; Zhongping Chen; Zekai Cui; Jiansu Chen; Shibo Tang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-19       Impact factor: 5.293

4.  Gut microbiota changes after metabolic surgery in adult diabetic patients with mild obesity: a randomised controlled trial.

Authors:  Eva Lau; Eugeni Belda; Paul Picq; Davide Carvalho; Manuel Ferreira-Magalhães; Maria Manuel Silva; Isaac Barroso; Flora Correia; Cidália Pina Vaz; Isabel Miranda; Adelino Barbosa; Karine Clément; Joel Doré; Paula Freitas; Edi Prifti
Journal:  Diabetol Metab Syndr       Date:  2021-05-21       Impact factor: 3.320

5.  The human gut microbiota contributes to type-2 diabetes non-resolution 5-years after Roux-en-Y gastric bypass.

Authors:  Jean Debédat; Tiphaine Le Roy; Lise Voland; Eugeni Belda; Rohia Alili; Solia Adriouch; Pierre Bel Lassen; Kazuyuki Kasahara; Evan Hutchison; Laurent Genser; Licia Torres; Camille Gamblin; Christine Rouault; Jean-Daniel Zucker; Nathalie Kapel; Christine Poitou; Geneviève Marcelin; Federico E Rey; Judith Aron-Wisnewsky; Karine Clément
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 6.  Evaluation of Dietary Assessment Tools Used in Bariatric Population.

Authors:  Marianne Legault; Vicky Leblanc; Geneviève B Marchand; Sylvain Iceta; Virginie Drolet-Labelle; Simone Lemieux; Benoît Lamarche; Andréanne Michaud
Journal:  Nutrients       Date:  2021-06-29       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.